Ernesto Rivera
Cardiovascular Disease · Amarillo, TXNPI 1639146533
Payments from drug & device makers
Across 241 payments — averaging $148.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$14K
- Medtronic$10K
- Abiomed$3K
- Penumbra, Inc.$3K
- Abbott$2K
- Boston Scientific$1K
- plus $3K from 15 others
What the payments were for
- Speaking & faculty fees$12,70035%
- Travel & lodging$14,67141%
- Food & beverage$8,21323%
- Education$2151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 29 | $14,022 |
| Medtronic(2 entities) | 83 | $10,254 |
| Abiomed | 8 | $2,732 |
| Penumbra, Inc. | 7 | $2,659 |
| Abbott | 27 | $2,160 |
| Boston Scientific | 10 | $1,222 |
| Terumo Medical Corporation | 9 | $730 |
| Cardinal Health 200 LLC | 6 | $393 |
| Philips North America LLC | 7 | $364 |
| Amgen | 17 | $339 |
| AstraZeneca | 9 | $226 |
| Acist Medical Systems, Inc. | 3 | $132 |
| Pfizer | 3 | $113 |
| AbbVie | 1 | $95 |
| Regeneron Healthcare Solutions, Inc. | 5 | $76 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $67 |
| Cardiovascular Systems Inc. | 3 | $62 |
| Amarin Pharma, Inc. | 4 | $52 |
| Novartis | 2 | $46 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| UCB, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$13,430
- Resolute$2,964
- Impella$2,639
- HawkOne$2,324
- Advisa$2,192
- Indigo System$1,577
- OMNILINK ELITE$1,110
- Indigo$1,040
- AngioJet Ultra 5000A$751
- Navicross$634
- Cardiovascular- Research only$243
- IN.PACT Admiral$240
- S.M.A.R.T. CONTROL Self-Expanding Nitinol Stent$150
- EluNIR Radaforolimus Eluting Coronary Stent System$150
- IGT D FM$149
- ClosureFast$125
- Xience V coronary stent system$108
- Biofreedom (DES)$106
- VYNDAQEL$103
How this compares
$35,798 in reported general payments places this provider in the 80th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Amarillo
- David BrabhamAmarillo$11.5M
- Alfred ChuAmarillo$1.3M
- Joaquin Martinez Arraras CaroAmarillo$1.2M
- Rajesh NambiarAmarillo$574K
- Ramin Farzaneh-FarDallas$17.1M
- Jeffrey GladdenDallas$15.8M
- Ann NavarDallas$14.5M
- Justin GrodinDallas$6.2M
- Christie BallantyneHouston$4.6M
- Syed NaqviHouston$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.